{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:44:51Z","timestamp":1761597891454,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.intimp.2017.12.022","type":"journal-article","created":{"date-parts":[[2017,12,26]],"date-time":"2017-12-26T18:40:38Z","timestamp":1514313638000},"page":"254-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Quercetin in the experimental liver fibrosis induced by carbon tetrachloride (CCl4)"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1789-8307","authenticated-orcid":false,"given":"Salvatore","family":"Chirumbolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geir","family":"Bj\u00f8rklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2017.12.022_bb0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.intimp.2017.03.029","article-title":"Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-\u043aB\/I\u043aB\u03b1, p38 MAPK, and Bcl-2\/Bax signaling","volume":"47","author":"Wang","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2017.12.022_bb0010","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2893.2008.00971.x","article-title":"Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats","volume":"15","author":"Tsai","year":"2008","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.intimp.2017.12.022_bb0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/138920112798868818","article-title":"Silymarin in the prevention and treatment of liver diseases and primary liver cancer","volume":"13","author":"F\u00e9her","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"10","key":"10.1016\/j.intimp.2017.12.022_bb0020","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/ptr.3207","article-title":"Milk thistle in liver diseases: past, present, future","volume":"24","author":"Abenavoli","year":"2010","journal-title":"Phytother. Res."},{"issue":"8","key":"10.1016\/j.intimp.2017.12.022_bb0025","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/jmf.2015.0104","article-title":"Beneficial effects of silymarin after the discontinuation of CCl4-induced liver fibrosis","volume":"19","author":"Clichici","year":"2016","journal-title":"J. Med. Food"},{"issue":"5","key":"10.1016\/j.intimp.2017.12.022_bb0030","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2174\/138955706777934937","article-title":"Naturally occurring NF-kappaB inhibitors","volume":"94","author":"Nam","year":"2006","journal-title":"Mini-Rev. Med. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2017.12.022_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174008","article-title":"Prevention of TGF-\u03b2-induced early liver fibrosis by a maleic acid derivative anti-oxidant through suppression of ROS, inflammation and hepatic stellate cells activation","volume":"12","author":"Yang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2017.12.022_bb0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejphar.2016.04.042","article-title":"Isorhamnetin attenuates liver fibrosis by inhibiting TGF-\u03b2\/Smad signaling and relieving oxidative stress","volume":"783","author":"Yang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2017.12.022_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/ar.23567","article-title":"Basement membrane type IV collagen and laminin: an overview of their biology and value as fibrosis biomarkers of liver disease","author":"Mak","year":"2017","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.intimp.2017.12.022_bb0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4137\/BMI.S10009","article-title":"Molecular serum markers of liver fibrosis","volume":"7","author":"Liu","year":"2012","journal-title":"Biomark. Insights"},{"issue":"2","key":"10.1016\/j.intimp.2017.12.022_bb0055","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.21802","article-title":"Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis","volume":"46","author":"Elsharkawy","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.intimp.2017.12.022_bb0060","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.febslet.2005.12.013","article-title":"Tea polyphenol epigallocatechin 3-gallate impedes the anti-apoptotic effects of low-grade repetitive stress through inhibition of Akt and NFkappaB survival pathways","volume":"580","author":"Sen","year":"2006","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.intimp.2017.12.022_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18010165","article-title":"PERM hypothesis: the fundamental machinery able to elucidate the role of xenobiotics and hormesis in cell survival and homeostasis","volume":"18","author":"Chirumbolo","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2017.12.022_bb0070","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/physrev.00061.2009","article-title":"Hepatocyte death: a clear and present danger","volume":"90","author":"Malhi","year":"2010","journal-title":"Physiol. Rev."},{"issue":"12","key":"10.1016\/j.intimp.2017.12.022_bb0075","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.bcp.2008.03.013","article-title":"Role of Bax in quercetin-induced apoptosis in human prostate cancer cells","volume":"75","author":"Lee","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"2016","key":"10.1016\/j.intimp.2017.12.022_bb0080","doi-asserted-by":"crossref","first-page":"35460","DOI":"10.1038\/srep35460","article-title":"Pharmacokinetic comparison between quercetin and quercetin 3-O-\u03b2-glucuronide in rats by UHPLC-MS\/MS","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2017.12.022_bb0085","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3892\/ol.2014.2159","article-title":"Quercetin induces HepG2 cell apoptosis by inhibiting fatty acid biosynthesis","volume":"8","author":"Zhao","year":"2014","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.intimp.2017.12.022_bb0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jcb.21977","article-title":"Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression","volume":"106","author":"Jeong","year":"2009","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.intimp.2017.12.022_bb0095","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.molcel.2007.12.029","article-title":"Bcl2 negatively regulates DNA double-strand-break repair through a nonhomologous end-joining pathway","volume":"29","author":"Wang","year":"2008","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.intimp.2017.12.022_bb0100","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1753-4887.2010.00301.x","article-title":"Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management","volume":"68","author":"Vargas","year":"2010","journal-title":"Nutr. Rev."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917304952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917304952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:08:00Z","timestamp":1761584880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576917304952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":20,"alternative-id":["S1567576917304952"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2017.12.022","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quercetin in the experimental liver fibrosis induced by carbon tetrachloride (CCl4)","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2017.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}